Search

Your search keyword '"Ukropec, Jon"' showing total 6 results
Start Over Author "Ukropec, Jon" Journal journal of clinical oncology
6 results on '"Ukropec, Jon"'

1. Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR

Author

Avet-Loiseau, Hervé, primary, San-Miguel, Jesus, additional, Casneuf, Tineke, additional, Iida, Shinsuke, additional, Lonial, Sagar, additional, Usmani, Saad Z., additional, Spencer, Andrew, additional, Moreau, Philippe, additional, Plesner, Torben, additional, Weisel, Katja, additional, Ukropec, Jon, additional, Chiu, Christopher, additional, Trivedi, Sonali, additional, Amin, Himal, additional, Krevvata, Maria, additional, Ramaswami, Priya, additional, Qin, Xiang, additional, Qi, Mia, additional, Sun, Steven, additional, Qi, Ming, additional, Kobos, Rachel, additional, and Bahlis, Nizar J., additional

Published
2021
Full Text
View/download PDF

2. Efficacy and safety of daratumumab, bortezomib, and dexamethasone (D-Vd) in relapsed or refractory multiple myeloma (RRMM) based on cytogenetic risk: Updated subgroup analysis of CASTOR.

Author

Weisel, Katja, primary, Spencer, Andrew, additional, Lentzsch, Suzanne, additional, Avet-Loiseau, Herve, additional, Mark, Tomer M., additional, Spicka, Ivan, additional, Bosi, Alberto, additional, Hungria, Vania TM, additional, Cavo, Michele, additional, Lee, Je-Jung, additional, Nooka, Ajay K., additional, Quach, Hang, additional, Munder, Markus, additional, Beksac, Meral, additional, Sonneveld, Pieter, additional, Soong, David, additional, Ukropec, Jon, additional, Qi, Ming, additional, and Mateos, Maria-Victoria, additional

Published
2019
Full Text
View/download PDF

3. Updated risk stratification model for smoldering multiple myeloma (SMM) incorporating the revised IMWG diagnostic criteria.

Author

San Miguel, Jesus, primary, Mateos, Maria-Victoria, additional, Gonzalez, Veronica, additional, Dimopoulos, Meletios A., additional, Kastritis, Efstathios, additional, Hajek, Roman, additional, Fernández de Larrea Rodríguez, Carlos, additional, Morgan, Gareth John, additional, Merlini, Giampaolo, additional, Mangiacavalli, Silvia, additional, Goldschmidt, Hartmut, additional, Cavo, Michele, additional, Kyriakou, Charalampia, additional, Qi, Ming, additional, Ukropec, Jon, additional, Weiss, Brendan M., additional, Cameron, Chris, additional, Rajkumar, S. Vincent, additional, Durie, Brian G., additional, and Kumar, Shaji, additional

Published
2019
Full Text
View/download PDF

4. Efficacy and safety of daratumumab, lenalidomide, and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): Updated subgroup analysis of POLLUX based on cytogenetic risk.

Author

Kaufman, Jonathan L., primary, Dimopoulos, Meletios A., additional, Leiba, Merav, additional, Morton, James, additional, Ho, P. Joy, additional, Kim, Kihyun, additional, Moreau, Philippe, additional, Sutherland, Heather J, additional, Iida, Shinsuke, additional, Kim, Jin Seok, additional, Prince, H. Miles, additional, Rocafiguera, Albert Oriol, additional, Bahlis, Nizar J., additional, Chari, Ajai, additional, Avet-Loiseau, Herve, additional, Chiu, Christopher, additional, Soong, David, additional, Ukropec, Jon, additional, Qi, Ming, additional, and San Miguel, Jesus, additional

Published
2019
Full Text
View/download PDF

5. Pomalidomide and dexamethasone (pom-dex) with or without daratumumab (DARA) in patients (pts) with relapsed or refractory multiple myeloma (RRMM): A multicenter, randomized, phase 3 study (APOLLO).

Author

Sonneveld, Pieter, primary, Terpos, Evangelos, additional, Dimopoulos, Meletios A., additional, Ukropec, Jon, additional, Smith, Elena, additional, Houkes, Nienke, additional, Schecter, Jordan Mark, additional, and Kastritis, Efstathios, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results